AiVF raked in $25 million in Series A funding led by Insight Partners and Adam Neumann's family office, the Tel Aviv fertility care startup exclusively tells Axios.
Why it matters: IVF clinics are struggling to keep up with mounting demand, as the industry faces a shortage of embryologists and high variability in success rates.
AiVF's software empowers embryologists with fertility intelligence to standardize and accelerate processes, boasting that it shortens the time to pregnancy and improves predictability.
The funding gives AiVF the financial wherewithal to enter the U.S. (where it is currently pursuing FDA approval) and to deepen its adoption across Europe.
State of play: IVF historically has been based upon subjective human analysis, with technology old-fashioned and costly, says Daniella Gilboa, an embryologist who co-founded AiVF in 2018 alongside IVF specialist Daniel Seidman.
Without technology, she says, "there's no way that [IVF clinics] can ever scale" to address today's access problem. "We call it the AI-human team."
Gilboa's ultimate vision? Revolutionize fertility care such that today's difficult and lengthy IVF experience becomes "quick and friendly".
How it works: AiVF uses machine learning to evaluate embryos during IVF, guiding embryologists as they identify and select what they believe are the embryos with the most promise of a healthy pregnancy.
Its AI is based upon what it says is the world's largest and most diverse clinic-derived datasets — the...
Read Full Story: https://www.axios.com/pro/health-tech-deals/2022/06/22/ivf-aivf-funding-adam-neumann-insight
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.